Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
How DPP-4 Works DPP-4 cleaves two amino acids from the N-terminus of GLP-1, converting the active hormone GLP-1(7-36) into an inactive fragment GLP-1(9-36)
Rapid weight loss from any causediet, bariatric surgery, or GLP-1 therapyincreases risk proportionally
At best, such products are misleading, said Jamie Alan, an associate professor of pharmacology and toxicology at Michigan State Universitys College of Human Medicine
Third-party reviews referenced in general category terms are not independently verified by this publication
The current medications vary in mechanism and magnitude: Semaglutide (Ozempic) targets GLP-1 receptors - around 15% average weight loss Tirzepatide (Mounjaro) targets GLP-1 + GIP - around 20% weight loss, often better GI tolerance Retatrutide (Phase 3 Trials) targets three receptors around 24% weight loss in trials, with broader metabolic effects The real risk is muscle mass loss
US$ 24.44
US$ 28.88
US$ 28.33
